High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer's disease

It has been reported that diffusion-weighted imaging (DWI) can detect white matter degeneration in the Alzheimer's disease (AD) brain. We hypothesized that imaging of the slow diffusion component using high b value DWI is more sensitive to AD-related white matter degeneration than is conventional DWI, and therefore we studied the effects of high b value on lesion-to-normal contrast and contrast-to-noise ratio (CNR). Seven AD patients and seven age-matched normal subjects were studied with full-tensor DWI at three different b values (1000, 2000, and 4000 s/mm(2)) without changing echo time or diffusion time, and the mean diffusivities in the parietal and occipital regions were measured. Statistical analyses revealed that use of higher b values significantly improves both lesion-to-normal contrast and CNR. We concluded that high b value DWI is more sensitive to AD-related white matter degeneration than is conventional DWI.

[1]  M. Castillo,et al.  Early abnormalities related to postinfarction Wallerian degeneration: evaluation with MR diffusion-weighted imaging. , 1999, Journal of computer assisted tomography.

[2]  B L Holman,et al.  The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  F. Barkhof,et al.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging , 1995, Neurology.

[4]  Elisabet Englund,et al.  Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia , 1998, Dementia and Geriatric Cognitive Disorders.

[5]  A. MacKay,et al.  In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.

[6]  C. Westin,et al.  Multi‐component apparent diffusion coefficients in human brain † , 1999, NMR in biomedicine.

[7]  C. Jack,et al.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.

[8]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[9]  A. Brun,et al.  Distribution of cerebral degeneration in Alzheimer's disease , 1976, Archiv für Psychiatrie und Nervenkrankheiten.

[10]  A. Delacourte,et al.  Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? , 1991, Journal of neurology, neurosurgery, and psychiatry.

[11]  A G Sorensen,et al.  Highly diffusion‐sensitized MRI of brain: Dissociation of gray and white matter , 2001, Magnetic resonance in medicine.

[12]  K Kuppusamy,et al.  High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. , 2000, AJNR. American journal of neuroradiology.

[13]  D. Norris,et al.  Biexponential diffusion attenuation in various states of brain tissue: Implications for diffusion‐weighted imaging , 1996, Magnetic resonance in medicine.

[14]  D L Buckley,et al.  Two‐component diffusion tensor MRI of isolated perfused hearts , 2001, Magnetic resonance in medicine.

[15]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[16]  H. Hanyu,et al.  Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease , 1998, Journal of the Neurological Sciences.

[17]  Y. Cohen,et al.  Non-mono-exponential attenuation of water and N-acetyl aspartate signals due to diffusion in brain tissue. , 1998, Journal of magnetic resonance.

[18]  D. Le Bihan,et al.  Water diffusion compartmentation and anisotropy at high b values in the human brain , 2000, Magnetic resonance in medicine.

[19]  M Takasaki,et al.  Increased water diffusion in cerebral white matter in Alzheimer's disease. , 1997, Gerontology.

[20]  P. Basser,et al.  Water Diffusion Changes in Wallerian Degeneration and Their Dependence on White Matter Architecture , 2000 .

[21]  G D Fullerton,et al.  An evaluation of the hydration of lysozyme by an NMR titration method. , 1986, Biochimica et biophysica acta.

[22]  K. Zou,et al.  Multi‐component apparent diffusion coefficients in human brain: Relationship to spin‐lattice relaxation , 2000, Magnetic resonance in medicine.

[23]  F Zito,et al.  High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  R. Edelman,et al.  Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[25]  S. Maier,et al.  Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. , 2001, Radiology.